Skip to main content
logo
Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.35
+0.74 (8.59%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3432296711745149
Market Cap Growth
400.86%241.79%-42.81%161.13%-69.83%166.34%
Enterprise Value
621.85503.56179.73214.4161.77174.77
Last Close Price
9.356.281.853.241.245.48
PE Ratio
--1.31-3.56-1.70-1.15-5.71
PS Ratio
69.8446.6512.9425.848.1433.21
PB Ratio
--1.05-1.39-3.651.245.85
P/TBV Ratio
-1.55-1.04-1.39-3.641.185.20
P/FCF Ratio
--8.70-1.70-2.11-1.29-5.97
P/OCF Ratio
--8.88-1.78-2.47-1.38-6.30
EV/Sales Ratio
126.80102.6834.7447.3411.2139.06
EV/EBITDA Ratio
--14.35-4.37-5.37-1.71-7.71
EV/EBIT Ratio
--13.75-4.24-5.24-1.67-7.34
EV/FCF Ratio
--19.14-4.56-3.86-1.78-7.02
Debt / Equity Ratio
-1.30-1.30-2.54-3.460.881.44
Debt / EBITDA Ratio
-8.20-8.20-3.08-3.01-1.35-1.68
Debt / FCF Ratio
-10.95-10.95-3.21-2.17-1.41-1.53
Net Debt / Equity Ratio
-1.28-1.28-2.44-3.330.941.09
Net Debt / EBITDA Ratio
-7.96-7.96-2.85-2.68-0.94-1.22
Net Debt / FCF Ratio
-10.62-10.62-2.97-1.92-0.98-1.11
Asset Turnover
0.060.060.060.050.070.08
Quick Ratio
1.021.020.211.030.942.76
Current Ratio
1.191.190.231.161.093.11
Return on Equity (ROE)
142.60%130.37%47.24%-3439.35%-120.10%-104.65%
Return on Assets (ROA)
-44.86%-44.86%-45.93%-42.11%-44.62%-43.60%
Return on Invested Capital (ROIC)
-53.44%-53.44%-56.13%-53.98%-57.15%-57.02%
Return on Capital Employed (ROCE)
-69.04%-69.04%-70.67%-53.50%-54.37%-48.73%
Earnings Yield
-50.74%-76.43%-28.11%-58.95%-87.10%-17.52%
FCF Yield
-7.68%-11.50%-58.90%-47.48%-77.40%-16.75%
Buyback Yield / Dilution
38.64%-0.22%-0.24%-5.19%-42.27%-46.84%
Total Shareholder Return
38.64%-0.22%-0.24%-5.19%-42.27%-46.84%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q